| 1840 |
1457: EMT |
1587: Fibroproliferative airway lesions |
Jan 30, 2019 |
Jan 30, 2019 |
1 AOP
|
| 2154 |
1457: EMT |
1458: Pulmonary fibrosis |
Jul 9, 2020 |
Jul 9, 2020 |
1 AOP
|
| 2614 |
1457: EMT |
1982: Metastasis, Breast Cancer |
Mar 22, 2022 |
Sep 26, 2023 |
1 AOP
|
| 3200 |
1457: EMT |
1651: Resistant gastric cancer |
Apr 23, 2024 |
Apr 23, 2024 |
1 AOP
|
| 3204 |
1457: EMT |
2013: Airway remodeling |
May 1, 2024 |
May 1, 2024 |
1 AOP
|
| 3306 |
1457: EMT |
885: Increase, Cancer |
Jul 18, 2024 |
Jul 18, 2024 |
1 AOP
|
| 2970 |
2152: Epigenetic modification process |
2153: Expression of factors ruling proliferation, modified |
Jul 27, 2023 |
Mar 27, 2025 |
1 AOP
|
| 3170 |
2212: Epididymal agenesis |
1758: Impaired, Spermatogenesis |
Mar 20, 2024 |
Dec 3, 2024 |
1 AOP
|
| 2453 |
1913: Endothelial cell dysfunction |
87: Release, Cytokine |
Aug 4, 2021 |
Aug 4, 2021 |
1 AOP
|
| 2511 |
1913: Endothelial cell dysfunction |
1666: dysfunction of microcirculation |
Oct 28, 2021 |
Oct 28, 2021 |
None
|
| 2711 |
2017: Endoplasmic reticulum stress |
1512: Unfolded Protein Response |
Jul 25, 2022 |
Jul 25, 2022 |
1 AOP
|
| 1106 |
1068: Endometrial squamous metaplasia, Increase |
1069: Increased, Hyperplasia (glandular epithelial cells of endometrium) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 3607 |
1068: Endometrial squamous metaplasia, Increase |
772: Increase, Hyperplasia (glandular epithelial cells of endometrium) |
Aug 26, 2025 |
Aug 26, 2025 |
None
|
| 3610 |
1068: Endometrial squamous metaplasia, Increase |
1070: Increased, adenosquamous carcinomas of endometrium |
Aug 26, 2025 |
Sep 18, 2025 |
1 AOP
|
| 1775 |
1539: Endocytosis |
898: Disruption, Lysosome |
Nov 12, 2018 |
Nov 12, 2018 |
2 AOPs
|
| 2680 |
2011: Emphysema |
2008: Chronic obstructive pulmonary disease |
Jun 17, 2022 |
Jun 17, 2022 |
1 AOP
|
| 3650 |
2363: Mito ROS dysfunction |
889: Proteostasis, impaired |
Oct 3, 2025 |
Oct 3, 2025 |
1 AOP
|
| 3691 |
2363: Mito ROS dysfunction |
1262: Apoptosis |
Nov 7, 2025 |
Nov 7, 2025 |
1 AOP
|
| 3498 |
2310: FAM50B/PTCHD3 expression |
2311: PI3K-Akt pathway |
Mar 2, 2025 |
Mar 2, 2025 |
1 AOP
|
| 1856 |
1600: Eczematous eruption |
1601: Scaling, Lichenification |
Feb 4, 2019 |
Feb 4, 2019 |
None
|
| 2493 |
1854: ACE2 dysregulation |
1497: Recruitment of inflammatory cells |
Oct 19, 2021 |
Oct 19, 2021 |
None
|
| 2532 |
1854: ACE2 dysregulation |
1954: Gut dysbiosis |
Dec 2, 2021 |
Dec 2, 2021 |
1 AOP
|
| 2831 |
1854: ACE2 dysregulation |
2096: (Micro)vascular dysfunction |
Jan 23, 2023 |
Feb 28, 2023 |
1 AOP
|
| 3223 |
2224: Dysregulation of transcriptional expression within PPAR signaling network |
179: Decrease, Fatty acid β-oxidation |
May 14, 2024 |
May 24, 2024 |
1 AOP
|
| 3224 |
2224: Dysregulation of transcriptional expression within PPAR signaling network |
2225: Disrupted Lipid Storage |
May 14, 2024 |
May 29, 2024 |
1 AOP
|